Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 16/20 | 0.58 |
| ▸ | MTOR | P42345 | 3/20 | 0.58 |
| ▸ | PIK3CB | P42338 | 16/20 | 0.56 |
| ▸ | PIK3CD | O00329 | 14/20 | 0.56 |
| ▸ | PIK3CG | P48736 | 10/20 | 0.56 |
| ▸ | PIK3R1 | P27986 | 5/20 | 0.56 |
| ▸ | PIK3C2B | O00750 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8008124 | 0.91 | PIK3CB (0.69) | PIK3CAMTORPIK3CBPIK3CDPIK3CG | |
| SCHEMBL8014950 | 0.90 | PIK3CA (0.69) | PIK3CAMTORPIK3CBPIK3CDPIK3CG | |
| SCHEMBL8010974 | 0.87 | PIK3CA (0.68) | PIK3CAMTORPIK3CBPIK3CDPIK3CG | |
| SCHEMBL8010377 | 0.86 | PIK3CA (0.67) | PIK3CAMTORPIK3CBPIK3CDPIK3CG | |
| SCHEMBL8008306 | 0.85 | PIK3CA (0.61) | PIK3CAMTORPIK3CBPIK3CDPIK3CG | |
| SCHEMBL8010379 | 0.84 | PIK3CA (0.59) | PIK3CAMTORPIK3CBPIK3CDPIK3CG | |
| SCHEMBL8012804 | 0.81 | PIK3CB (0.69) | PIK3CAMTORPIK3CBPIK3CDPIK3CG | |
| SCHEMBL8009124 | 0.81 | PIK3CA (0.54) | PIK3CAMTORPIK3CBPIK3CDPIK3CG | |
| SCHEMBL1309409 | 0.81 | PIK3CA (0.70) | PIK3CAMTORPIK3CBPIK3CDPIK3CG | |
| SCHEMBL8008709 | 0.80 | PIK3CA (0.52) | PIK3CAMTORPIK3CBPIK3CDPIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009093981-A1 | TRIAZINE COMPOUNDS AS KINASE INHIBITORS | S BIO PTE LTD (SG) | 2009-07-30 | — | — | WO | disclosed |